May 01 2026

New treatment cuts bad cholesterol by nearly 50% without statins

A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key protein that keeps “bad” LDL cholesterol circulating in the blood. By blocking this protein, cells can absorb more cholesterol instead of letting it build up in arteries, dramatically lowering levels linked to heart disease.

Read More

From Science Daily • • 0

May 01 2026

New treatment cuts bad cholesterol by nearly 50% without statins

A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key protein that keeps “bad” LDL cholesterol circulating in the blood. By blocking this protein, cells can absorb more cholesterol instead of letting it build up in arteries, dramatically lowering levels linked to heart disease.

Read More

From Science Daily • • 0

May 01 2026

New treatment cuts bad cholesterol by nearly 50% without statins

A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key protein that keeps “bad” LDL cholesterol circulating in the blood. By blocking this protein, cells can absorb more cholesterol instead of letting it build up in arteries, dramatically lowering levels linked to heart disease.

Read More

From Science Daily • • 0

Apr 30 2026

How can a heart rate tracker help you?

How can a heart rate tracker help you? Dr Oscar explains.

Read More

From BBC News - Health • • 0

Apr 30 2026

Scientists restore memory by blocking a single Alzheimer’s protein

Researchers have identified a new potential weapon against Alzheimer’s: blocking a protein called PTP1B. In mice, this approach boosted memory and helped brain immune cells clear harmful plaque buildup. Since PTP1B is also linked to diabetes and obesity—both risk factors for Alzheimer’s—it could offer a broader treatment strategy.

Read More

From Science Daily • • 0